Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/05/2012
PIL Rhinocort Aqua 64 micrograms, nasal spray

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
Updated on 20/04/2012 and displayed until 11/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to instructions about overdose
Updated on 01/05/2009 and displayed until 20/04/2012
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/06/2008 and displayed until 01/05/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change due to user-testing of patient information
Updated on 05/06/2008 and displayed until 25/06/2008
Reasons for adding or updating:
  • Addition of Marketing Authorisation Holder
Updated on 05/05/2004 and displayed until 05/06/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  budesonide